Iskra Pusic

7PUBLICATIONS
46CO-AUTHORS
Gene and molecular therapyBiologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 09, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment Trial.

|May 01, 2025
Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study.

Rubina Sharma, Noa G Holtzman, Iskra Pusic

|Nov 22, 2024
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation.

Ramzi Abboud, Mark A Schroeder, Michael P Rettig

|Oct 25, 2024
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis.

Joseph Pidala, Jongphil Kim, Denise Kalos

|Dec 09, 2023
Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease.

Iskra Pusic, Catherine Lee, Muthu Veeraputhiran

|May 26, 2023
Clonal hematopoiesis in survivors of childhood cancer.

Danielle Novetsky Friedman, Irenaeus C C Chan, Chaya S Moskowitz

Pageof 2

Frequent Collaborators

2 joint publications

Geoffrey Uy

2 joint publications

John F DiPersio

2 joint publications

Stephanie J Lee

2 joint publications

William J Hogan